CD73-IN-3 |
Catalog No.GC62331 |
CD73-IN-3 es un potente inhibidor de CD73 (IC50 = 7,3 nM en el ensayo de células humanas Calu6). CD73-IN-3, ejemplo 2 extraÍdo de la patente WO2019168744 A1, tiene potencial para la investigaciÓn del cÁncer.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2375815-63-5
Sample solution is provided at 25 µL, 10mM.
CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay). CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research[1].
CD73-IN-3 inhibits CD73 activity in human serum with an EC50 of 0.213 μM. CD73-IN-3 inhibits CD73 activity in human serum by 56.8%, 71.7% and 76.9% at 0.52 μM, 1.56 μM, 4.68 μM,respectively[1].In Calu6 human cell assay against CD73, the IC50 for CD73-IN-3 against CD73 is 0.0073 uM[1].
[1]. Robert Dean Dally, et al. Cd73 inhibitors. Patent WO2019168744 A1.
Average Rating: 5
(Based on Reviews and 9 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *